Greenwich Wealth Management LLC Pfizer Inc Transaction History

Greenwich Wealth Management LLC

$1.47 Billion
Q3 2024

A detailed history of Greenwich Wealth Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Greenwich Wealth Management LLC holds 136,463 shares of PFE stock, worth $3.6 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

136,463

Previous 132,847 2.72%

Holding current value

$3.6 Million

Previous $3.72 Million 6.24%

% of portfolio

0.27%

Previous 0.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$27.7 - $31.39 $100,163 - $113,506	3,616 Added 2.72%	136,463 $3.95 Million
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $16,216 - $19,003	-642 Reduced 0.48%	132,847 $3.72 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $277,256 - $318,378	10,709 Added 8.72%	133,489 $3.7 Million
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $9,197 - $11,946	-352 Reduced 0.29%	122,780 $3.54 Million
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $32,410 - $37,885	-1,010 Reduced 0.81%	123,132 $4.08 Million
Q2 2023 Jul 31, 2023	BUY	$36.12 - $41.79 $15,820 - $18,304	438 Added 0.35%	124,142 $4.55 Million
Q1 2023 Apr 24, 2023	BUY	$39.39 - $51.28 $18,158 - $23,640	461 Added 0.37%	123,704 $5.05 Million
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $5,636 - $7,357	135 Added 0.11%	123,243 $6.32 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $15,534 - $18,964	-355 Reduced 0.29%	123,108 $5.39 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $22,148 - $26,260	476 Added 0.39%	123,463 $6.47 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $10,019 - $12,415	-219 Reduced 0.18%	122,987 $6.37 Million
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $109,415 - $162,190	2,648 Added 2.2%	123,206 $7.28 Million
Q3 2021 Oct 19, 2021	BUY	$39.25 - $50.42 $359,490 - $461,796	9,159 Added 8.22%	120,558 $5.19 Million
Q2 2021 Jul 27, 2021	BUY	$35.91 - $40.68 $143,424 - $162,475	3,994 Added 3.72%	111,399 $4.36 Million
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $33,623 - $37,921	-1,004 Reduced 0.93%	107,405 $3.89 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $27,378 - $34,814	-818 Reduced 0.75%	108,409 $3.99 Million
Q3 2020 Oct 29, 2020	BUY	$31.75 - $37.25 $730 - $856	23 Added 0.02%	109,227 $4.01 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $17,499 - $21,229	581 Added 0.53%	109,204 $3.57 Million
Q1 2020 May 12, 2020	BUY	$27.03 - $38.62 $100,416 - $143,473	3,715 Added 3.54%	108,623 $3.55 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $15,702 - $17,820	477 Added 0.46%	104,908 $4.11 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $46,233 - $59,950	-1,423 Reduced 1.34%	104,431 $3.75 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $118,816 - $133,403	-3,213 Reduced 2.95%	105,854 $4.59 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $24,937 - $27,398	-665 Reduced 0.61%	109,067 $4.63 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $21,850 - $24,912	568 Added 0.52%	109,732 $4.79 Million
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $26,507 - $32,151	769 Added 0.71%	109,164 $4.81 Million
Q2 2018 Jul 25, 2018	BUY	$32.98 - $35.16 $96,466 - $102,842	2,925 Added 2.77%	108,395 $3.93 Million
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $12,668 - $14,696	397 Added 0.38%	105,470 $3.74 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $105,267 - $111,692	3,165 Added 3.11%	105,073 $3.81 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $431,799 - $475,675	-13,929 Reduced 12.02%	101,908 $3.64 Million
Q2 2017 Aug 14, 2017	BUY	N/A	115,837	115,837 $3.89 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwich Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwich Wealth Management LLC with notifications on news.

Account

Greenwich Wealth Management LLC Pfizer Inc Transaction History